Terns Pharmaceuticals, Inc. (TERN) Total Assets by Year
Terns Pharmaceuticals, Inc. closed fiscal year 2025 with $1.0B in total assets, $18.6M in total liabilities and $1.0B in shareholder equity. This represents an increase of 181.7% from the prior fiscal year. The table below carries 6 fiscal years, from 2020 to 2025, and the quarters Terns Pharmaceuticals, Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
TERN Balance Sheet by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | FY2510-K | FY2410-K | FY2310-K | FY2210-K | FY2110-K | FY2010-K |
|---|---|---|---|---|---|---|
| Total Assets | $1.0B+181.7% | $363.9M+35.5% | $268.5M-6.4% | $287.0M+70.8% | $168.1M+82.1% | $92.3M |
| Total Liabilities | $18.6M+2.7% | $18.1M+37.3% | $13.2M+30.4% | $10.1M+29.8% | $7.8M-96.3% | $209.7M |
| Total Equity | $1.0B+191.0% | $345.9M+35.4% | $255.4M-7.8% | $276.9M+72.8% | $160.3M+236.5% | -$117.4M |
TERN Balance Sheet by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q | Q1'2410-Q | Q4'2310-K | Q3'2310-Q | Q2'2310-Q | Q1'2310-Q |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $1.0B+181.7% | $301.7M-20.2% | $320.4M+38.8% | $339.3M+37.5% | $363.9M+35.5% | $378.2M+39.2% | $230.9M-20.3% | $246.8M-18.1% | $268.5M-6.4% | $271.7M+41.1% | $289.7M+100.0% | $301.3M+92.3% |
| Total Liabilities | $18.6M+2.7% | $17.6M+27.8% | $15.2M+24.5% | $13.3M+32.1% | $18.1M+37.3% | $13.8M+3.8% | $12.2M-21.5% | $10.0M-26.1% | $13.2M+30.4% | $13.3M+49.1% | $15.5M+103.4% | $13.6M+71.0% |
| Total Equity | $1.0B+191.0% | $284.1M-22.1% | $305.2M+39.6% | $326.0M+37.7% | $345.9M+35.4% | $364.5M+41.0% | $218.7M-20.2% | $236.7M-17.7% | $255.4M-7.8% | $258.4M+40.7% | $274.1M+99.8% | $287.7M+93.4% |
What total assets means
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders.
More Terns Pharmaceuticals, Inc. financials
Frequently Asked Questions
What was Terns Pharmaceuticals, Inc.'s total assets in fiscal year 2025?
Terns Pharmaceuticals, Inc. closed fiscal year 2025 with $1.0B in total assets, $18.6M in total liabilities and $1.0B in shareholder equity.
How fast is Terns Pharmaceuticals, Inc.'s total assets growing?
Terns Pharmaceuticals, Inc. (TERN) total assets rose by 181.7% year over year, from $363.9M to $1.0B in fiscal year 2025.
How has Terns Pharmaceuticals, Inc.'s total assets changed over the years?
Across the 6 fiscal years this page covers, Terns Pharmaceuticals, Inc. (TERN) total assets went from $92.3M in fiscal year 2020 to $1.0B in fiscal year 2025.
What was Terns Pharmaceuticals, Inc.'s total assets in the most recent quarter?
Terns Pharmaceuticals, Inc. (TERN) reported $1.0B in total assets in Q4 2025. This represents an increase of 181.7% from the same quarter a year earlier.
What does total assets mean on a financial statement?
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders. This page lists what Terns Pharmaceuticals, Inc. (TERN) reported on that line in every period on record.